Ann: Appendix 4C - quarterly, page-35

Below is my opinion and research only. It is not financial advice:

Good research, however why you have oppies exposure makes little financial sense to me.

a) If IBX decide to raise down the track, shares will be diluted and oppies will be sold down.
b) Shares are exposed to risk: However, IBX shares own the patents, have procured fast track FDA designation, have down something that few on the forum discuss, that is made progress - with nanoparticle manufacturing and toxicology clearance. There will always be value attached to the shares. Furthermore, IBX has no creditors, no debt and no convertible notes. Oppies value the shares at 6 cents at the moment. As you hold oppies, is this where you value IBX shares?
c) If that's the case, IBX shares are trading at 2.7 cents - less than half the option incidental value.
d) Conclusion: Oppies seem to be a much more expensive form of exposure to IBX considering all the risks you have mentioned.